Independence Blue Cross Restricts Weight Loss Drug Coverage Starting January 1, 2025, Independence Blue Cross (IBX), the largest health insurer in southeastern Pennsylvania, will no longer cover certain weight loss medications, including GLP-1 receptor agonists like Wegovy and Ozempic, when prescribed solely for managing weight. The company will continue covering these medications for individuals with FDA-approved conditions such as Type 2 diabetes or cardiovascular disease. This change impacts both group and individual commercial plan holders, shifting the full cost of these drugs—ranging from $700 to $1,350 per month—to patients who…
Read MoreWhy New Insurance Rules Could Make Weight Loss Treatments Harder to Access
